Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With Osteosarcoma [Phase 1, Phase 2]

View source ↗

Summary

A study evaluating the safety and efficacy of ALMB-0168 in osteosarcoma across Phase 1 and Phase 2 is listed, with status currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• ALMB-0168

Snippet

Sponsor: AlaMab Therapeutics (Shanghai) Inc. | Conditions: Osteosarcoma | Phase 1, Phase 2 | Status: UNKNOWN